The University of Louisville has selected a 30-plus-year medical and higher education veteran to transform its health enterprise and lead its School of Medicine, one of the oldest and most celebrated medical schools in North America.  

The Board of Trustees today named Jeffrey R. Bumpous, MD, the university’s new executive vice president of health affairs and dean of the School of Medicine, effective July 1. In addition to providing strategic leadership and financial oversight for the medical school and its academic programs, clinical activities and research, the EVP/dean will strengthen the partnership with the university’s primary provider affiliate, UofL Health, one of Louisville’s largest employers. Bumpous will work closely with UofL Health’s CEO to ensure continued financial stability and advancement of both organizations’ respective missions, while advancing the goal of creating an interdependent, shared academic health enterprise.

“I am confident Dr. Jeffrey Bumpous is the right leader at the right time to further advance the tremendous partnership between the University of Louisville and UofL Health,” said UofL President Kim Schatzel. “Both institutions are critical to address the crisis of health care workforce shortages and ensure Kentuckians in both urban and rural areas have access to high-quality health care.” 

Bumpous, an otolaryngologist – head and neck surgeon, has served as UofL’s interim School of Medicine dean and vice president of academic medical affairs since June 2023.  He earned a doctor of medicine degree at UofL and has been a faculty member since 1994. He is the J. Samuel Bumgardner Professor and chairman of the Department of Otolaryngology – Head and Neck Surgery and Communicative Disorders and is an associate clinical director at UofL Health - Brown Cancer Center.  

“This appointment is a testament to Dr. Bumpous’ courageous leadership and commitment to advancing medical education and research at UofL,” said Gerry Bradley, provost and executive vice president.  “He has the deep respect of his colleagues and will continue to prepare students for success in a rapidly changing clinical environment.” 

Faculty members at the University of Louisville Health Sciences Center (HSC) have launched an innovative website which serves as a one-stop resource for hands-on teaching tools. Developed by four faculty members as a part of their Leadership and Innovation in Academics Matter (LIAM) project, the website features a variety of novel teaching methods to educate the next generation of medical professionals.  

The project was facilitated by the LIAM program, a 10-month training program designed to develop the next generation of leaders at the University of Louisville. LIAM participants are immersed in monthly face-to-face workshops and weekly asynchronous content with capstone team projects preparing them to lead in an academic setting.

Motivated by research indicating that learners are more successful when less traditional methods of teaching are incorporated, Drs. Bickel (Pediatrics), Javid (Surgery), Hilgefort (Family and Sports Medicine), and Villalobos (Dentistry) developed Louisville Teaches, a comprehensive website for all faculty to access resources to help them integrate unique methods into their teaching such as using game-based learning, flipped classroom methods, and artificial intelligence. The department of Pediatrics has already begun using the resources.

LIAM is administered by the HSC Office of Professional & Educational Development and has more than 200 graduates, including faculty from all four UofL HSC schools, the College of Business, College of Education and Human Development and the College of Arts & Sciences.

The cohort celebrated their graduation from the LIAM program this week, but the doctors that developed Louisville Teaches plan to continue to add new content with monthly updates to the website. It is the hope of the team that future cohorts of the LIAM program will elect to expand Louisville Teaches through their own projects.

“As the LIAM program works to develop the next generation of leaders at UofL, we wanted to design a project that would extend far beyond the parameters of our cohort, creating a lasting impact on the School of Medicine and its doctors, the medical students, and the patients who receive care from these individuals,” says Scott Bickel, M.D., associate professor of Pediatrics. 

The website not only highlights the innovative work of faculty members, but also showcases collaborative efforts across various disciplines. By sharing resources, the project encourages faculty to incorporate these new methods into their teachings, which enhances our student’s overall educational experience.

“We are incredibly proud of the collaborative and creative efforts by our faculty in developing these resources,” said Jeffrey Bumpous, M.D., interim dean of the School of Medicine. “Louisville Teaches exemplifies our commitment to educational innovation, providing our faculty with the tools to create a dynamic learning environment for our medical students and others.”

Faculty and staff are encouraged to submit their own favorite resources or examples to be included on the site. For more information on the resources and to see how they can be applied in your own classroom, please visit louisvilleteaches.org.

Whether it is a day on the lake or an afternoon working in the yard, exposure to high temperatures may harm your health by impacting your immune system, according to University of Louisville research.

Periods of extreme heat often result in an increase in deaths, mostly related to heart conditions. A UofL research study shows that heat also can impair the immune system and increase damaging inflammation, according to Daniel Riggs, assistant professor of environmental medicine and affiliated with UofL’s Christina Lee Brown Envirome Institute.

Riggs and his colleagues recorded levels of immune cells and biomarkers in the blood of 624 participants in Louisville during summer months. They then compared those levels with the Universal Thermal Climate Index for that day, which factors in air temperature, relative humidity, wind speed and ultraviolet radiation levels as a measure of heat exposure.

They found that when it was hotter, the participants had higher levels of immune molecules in their blood, indicating a general immune response and inflammation, as well as lower levels of B-cells, which allow the body to fight specific infections. This means that with higher heat, people may be more susceptible to infection and more sensitive to environmental exposures, which in turn can contribute to worsened heart disease.

“We know that certain changes in the immune system and increased inflammation are a leading mechanism in many types of cardiovascular disease. Our findings suggest that heat exposure could be contributing to these processes that ultimately lead to greater risk of cardiovascular disease,” Riggs said.

Riggs presented the research at the American Heart Association Epidemiology, Prevention, Lifestyle and Cardiometabolic Health Conference in March.

The 2024-2025 academic year marks a significant milestone for the University of Louisville School of Medicine as it celebrates its tenth year of integrating the eQuality program into its curriculum. This innovative program focuses on offering training for future physicians on the unique healthcare needs of people who are lesbian, gay, bisexual, transgender (LGBT), gender nonconforming (GNC), or born with differences of sex development (DSD).

eQuality is more than just an educational program; it is an integrated educational model that incorporates content throughout required medical curricula, promoting student and faculty development and institutional change. The curriculum is based on medical education competencies from the Association of American Medical Colleges.

“eQuality allows us to instill in current and future physicians the importance of delivering evidenced based, affirming healthcare that is tailored to fit patient needs, specifically those of the LGBTQ+ community,” said Lisa Gunterman, director of the HSC LGBT Center.

Individuals who identify as LGBTQ+ face unique challenges when seeking healthcare. These challenges are often overlooked and result in decreased access to care or willingness to seek care. This disparity has led to an increase in medical morbidity and mortality for these patients.

The UofL School of Medicine is committed to bridging the gap in training health care professionals for these patients, with the goal of diminishing disparities among this community. The eQuality program trains accepting, informed, patient-centered physicians.

“Entering the tenth year of the eQuality program at the UofL School of Medicine, we would like to recognize the efforts made by our students, staff, and physicians to change the outlook of health care for the LGBTQ+ communities and encourage other medical institutions to adopt eQuality resources for use within their own teachings,” said Ann Shaw, MD, vice dean for Undergraduate Medical Education.

Designed for continuous assessment, refinement, and dissemination, the eQuality program aims to drive global improvement in medical education and physician competence. As the nation’s pilot site for eQuality, the UofL School of Medicine has set a precedent for success and serves as a model for other institutions.

The eQuality program represents a decade of progress and a promising future of continued advocacy and excellence in medical education. The UofL School of Medicine remains dedicated to this crucial initiative to create a more inclusive and equitable healthcare system for all.

Zoha Mian, a rising fourth-year medical student at the University of Louisville School of Medicine has been awarded the Benjamin H. Kean Travel Fellowship by the American Society of Tropical Medicine and Hygiene. The Benjamin H. Kean Travel Fellowship in Tropical Medicine is awarded annually to support medical students involved in clinical or research electives in tropical areas. This fellowship will support her research efforts in Tanzania, where she will focus on combating corneal disease and improving eye health in low and middle-income countries.

Mian’s journey to global health began when she pursued a master’s degree at the London School of Hygiene and Tropical Medicine (LSHTM). “Ultimately, I pursued this master’s to learn how to be a researcher,” said Mian, “I hope to use this experience to spearhead other global health research projects in the future and learn from eye health researchers and doctors abroad on how I can eliminate blindness and increase access in my own setting back home in America.”

The University of Louisville School of Medicine faculty stand as a pillar of support in Mian’s journey. “The faculty members at the University of Louisville were instrumental in facilitating my attainment of this award and providing invaluable assistance in navigating logistical challenges,” said Mian. This support has been crucial in her preparation for the fellowship and the work she plans to accomplish while in Tanzania.

Mian’s decision to focus her research endeavors in Tanzania was guided by the country's pivotal role in global health initiatives and the guidance of her mentors from LSHTM, Drs. John Buchan, Astrid Leck, Tara Mtuy, Robert Butcher, and Einoti Matayan. Their extensive research in tackling fungal keratitis provided Mian with the insight and support needed to develop this project.

Inspired by a diverse array of experiences, including attendance at the Global Ophthalmology Summit and insights into the escalating burden of untreated corneal disease in low and middle-income countries, Mian embodies a determination to institute meaningful change in the landscape of eye health. Through her research endeavors in Tanzania, she aspires to not only address the gaps in fungal keratitis treatment but also play a part in paving the way for a more comprehensive, inclusive approach to ocular health that transcends borders and transforms lives.

As Mian embarks on this transformative journey, the ULSOM stands behind her, confident that her research will make strides in advancing global eye health.  Congratulations to Zoha Mian on receiving the Kean Fellowship and best wishes for her research efforts in Tanzania!

The University of Louisville School of Medicine’s class of 2024 embarked on their medical journey amidst a time of great uncertainty in the world – the COVID-19 pandemic. In a time when physical classrooms were swapped for virtual ones, these aspiring physicians remained resilient in their journey to medicine. Andrew Willett, 2024 MD candidate, is among those who navigated through the unprecedented challenges of virtual learning as an added stressor to his medical school experience. Nonetheless, Willett was determined to continue pursuing his goal of becoming a physician.

“I was so grateful to be entering medical school that I didn’t think about the pros and cons of starting during a pandemic – I was simply ready to begin this next phase of my career and wasn’t going to alter my trajectory given the global circumstances,” said Willett.

Pursuing his medical career during a pandemic was not without challenge. Willett highlighted the difficulties of transitioning from an in-person curriculum to a virtual one. This transition created a learning curve and made it challenging to adapt to the pace of medical school. The virtual nature of his M1 year, along with the hospitals being overwhelmed by the pandemic, made clinical experiences as an early medical student difficult to pursue. Social gatherings were far and few in between which didn’t allow for much in-person connection as a class.

Through all the struggle of the virtual nature of his M1 year, Willett still feels fortunate to have started medical school when he did as it encouraged resiliency. “The biggest skill I learned from this experience was becoming comfortable with the unknown and learning how to deal with circumstances that I didn’t create,” said Willett. The commotion during the pandemic allowed Willett to grow in ways that will stay with him through the entirety of his medical career.

Willett recalled a moment that will stick with him forever as a result of this experience. “I remember being vaccinated early during the vaccination efforts while simultaneously learning about the principles of immunology and virology during the second semester of our M1 year – that was a very cool, full-circle experience that I won’t forget.”

Willett does not view the pandemic as an experience that negatively affected his medical career; instead, it made him more prepared for the next steps of his medical journey.

“I feel academically and clinically equipped to work as a physician, and feel like I have a unique mindset and attributes that will help me be effective at the next institution I join during residency,” said Willett, “I have learned and grown so much throughout my time at ULSOM and am forever thankful for the community of friends and mentors that have prepared me to enter into this next stage of my life and career.”

The University of Louisville School of Medicine holds deep admiration for the unwavering resilience and dedication demonstrated by our medical students throughout the challenges of the pandemic and the subsequent return to in-person learning. We are in awe of the accomplishments achieved by the class of 2024 as they continue their journey in the medical field. We look forward to seeing the remarkable contributions each graduate will make to the advancement of healthcare in our world.

Class of 2024 Graduation Live-Stream

Muhlenberg County native Caitlan Jones is completing medical school in the hospital where she was born in Madisonville, Kentucky.

Jones is part of the University of Louisville School of Medicine’s Trover Rural Track, based at Baptist Health Deaconess Madisonville, which offers students the opportunity to complete medical school in a small community.

It has been a perfect fit for Jones, who will receive her medical degree on May 11 from the UofL School of Medicine and hopes to practice in a rural community.

“I want to practice wide-spectrum family medicine in Western Kentucky. I like the community clinics and small towns,” Jones said. “My husband is from Owensboro and we both like our families, so we want to stay in Western Kentucky.”

Physicians are badly needed in rural areas of the commonwealth, where many communities are medically underserved.

“If you look on a map of health professional shortage areas, almost all of Western Kentucky is blocked out. They don’t have enough of anything,” Jones said.

Jones, who grew up on a farm with her three siblings, is grateful for her down-to-earth upbringing.

“I was raised by a great set of parents. My dad has made an impressive career in the coal mines, runs the family farm and in his little spare time he is a volunteer firefighter,” Jones said. “I am outgoing and talkative just like my dad, but I don’t think I could ever be as hardworking. My mom works as a bookkeeper, taught us about Jesus and was very involved in our education.”

She also is inspired by her parents’ generosity in the community.

“Seeing how hard my parents worked and how involved they were in communities was enough for me to say I want to come back somewhere similar to home and be involved in that same way.”

Jones sees medicine as a perfect way for her to be involved.

“I like that it’s challenging, I’m always reading and learning and problem solving,” she said. “I also think there is a gap in medicine. I have a really strong faith and I think you miss that a lot in the medical community—doctors that pray and believe in healing and the other side that so many patients also do. So, filling that gap is a big part of why I am in medicine. I want to love others.”

After being introduced to Trover as an undergraduate at Murray State University, Jones spent a summer participating in the Trover Campus Rural Scholars Program. That experience sealed her decision to practice rural medicine.

“I was offered acceptance at four medical school programs, but I chose UofL largely because of the great experience I had in undergrad at the Trover Campus,” Jones said.

Although she did part of her training in Louisville, Jones likes the environment in Madisonville, which provided more one-on-one time with attending physicians.

“I see people all the time I know. It’s different to be somewhere you know people but also, it’s a different feeling from a big university hospital,” Jones said. “People know my parents or I know people’s parents, so it’s a different level of connection.” 

Jones will reach her goal a year sooner than most medical students thanks to Trover’s Rural Medicine Accelerated Track (RMAT), a program allowing students who intend to practice in a rural Kentucky community to finish medical school in three years rather than the typical four.

Jones and Bradley Watson, the 2024 graduates of the RMAT, are completing the program a decade after the first graduate finished in 2014. Jones and Watson also both were awarded the 2023 Anthem Medicaid Rural Medicine Scholarship, which supports RMAT students.

In July, Jones will begin residency training at the UofL Owensboro Family Medicine Residency Program.

“It doesn’t really feel real,” she said. “I am finishing a year early so it doesn’t feel like I’ve been doing it that long. But I’m really excited to see what comes next.”

Watch the video:

A team of researchers at the University of Louisville has been honored for their pioneering work in uncovering a new connection between cancer treatment and kidney disease.

Their award-winning study, named Paper of the Year by the American Journal of Physiology, sheds light on the heightened risk of kidney complications in cancer patients undergoing treatment. The study revealed that cancer itself may harm the kidneys, but that damage and scarring is intensified when patients take cisplatin, a commonly used chemotherapy drug. 

“Everything in your body is connected, from your internal systems to the medications we take,” said Andrew Orwick, lead author and recent doctoral graduate in pharmacology and toxicology.

Orwick’s doctoral research in the laboratory of researchers Leah Siskind and in collaboration with Levi Beverly, both from the UofL School of Medicine and Brown Cancer Center, examined the interplay of cisplatin and lung cancer, which is highly prevalent in Kentucky.

“By better understanding what those interactions are and how they happen,” he said, “we can take them into consideration and improve outcomes for the patient.”

Ultimately, that could lead to new diagnostics, more effective drugs and treatment plans that better consider the patient’s overall health and avoid or limit kidney damage.

Chronic damage to the kidneys can cause nausea, vomiting, fatigue, high blood pressure and even death, without transplant or dialysis. Because symptoms progress slowly, patients may not notice the condition until its advanced stages. Even so, current testing methods are difficult and invasive.

The UofL researchers think their work could help clinicians better predict not only which patients will react negatively to cisplatin and other chemotherapy drugs, but also identify potential kidney problems early. The goal is to better understand the underlying mechanisms and biomarkers, so clinicians can make more informed decisions.

“Obviously, addressing the cancer is first and foremost, but if we can do that while also preserving the patient’s overall health and feeling of health, that’s optimal,” said Siskind, a professor and senior author on the study. “The great news is that the fact that we’re even having this conversation means we’re making progress in solving cancer — we’re considering not only life, but the quality of that life.”

Siskind said the paper represents a paradigm shift in how researchers think about and treat both cancer and kidney disease. As it stands, no treatment for this form of kidney disease has made it past a phase 2 clinical trial or been approved for use in patients. This research could also help inform better drugs and experiments to fill that need. 

That innovative thinking and broad impact is likely part of why this work was selected as Paper of the Year, said Jon Klein, interim executive vice president for research and innovation.

“Being selected for this honor is a massive accomplishment and underpins the immense value of the research being done by this team and across UofL,” Klein said. “This is work that truly can save and improve lives.” 

Many people enjoy spending time in nature, basking in the peaceful atmosphere of forests, parks and green spaces. It is widely believed that exposure to plants and trees improves physical and mental wellbeing, and living in areas with an abundant tree canopy is associated with better health. But can these health benefits be proven scientifically?

A new discovery at the University of Louisville may help scientists test the effects of exposure to green plants “greenness” on health. Pawel Lorkiewicz, associate professor of chemistry and environmental medicine at UofL’s Christina Lee Brown Envirome Institute, measured a person’s exposure to trees and plants by testing their urine.

Limonene is a nontoxic substance emitted into the air by many trees and plants. Concentrated limonene has a lemony smell and is used in perfumes, foods, cleaning and other household products. When a person breathes concentrated limonene, the body breaks it down into metabolites which can be measured in their urine.

These metabolites also are in a person’s urine after they spend time in a forest, according to Rachel Keith, associate professor at the Envirome Institute who conducted the study. This means the metabolites can be used to measure a person’s exposure to trees and plants. Comparing this exposure with health information may help researchers more accurately determine whether time spent in nature is beneficial for an individual’s health.

“Even though we may not smell limonene exactly, usually we can tell that we are surrounded by trees and greenness because of the smell. Parks and forests, or even meadows or larger green spaces have a characteristic smell because of plant volatile organic compounds such as limonene,” Lorkiewicz said.

For several years, Envirome Institute researchers have been studying the health effects of living near trees and greenness. As part of the Green Heart Project, they planted trees and shrubs in specific neighborhoods, measuring changes in the residents’ health compared with those living in areas with fewer trees. But the researchers found it challenging to accurately measure an individual’s actual exposure to trees. There may be many trees where they live, but they spend much of their time working in tree-sparse locations or indoors, insulated from trees and plants.

So the team searched for a way to measure how much time an individual spent around greenness. Because many trees and plants release significant amounts of limonene into the air, they developed a method to test for limonene exposure using urine, which is easy to collect.

After testing the urine of people who smelled pure limonene from a vial, they compared those results with urine from people who spent time walking in a forest. They found the same metabolites in the urine of both groups, tagging three of them as reliable biomarkers of exposure to greenness.

“It was very exciting. That’s what constitutes a biomarker, something was released by trees in real life, metabolized by our bodies and found in our urine, not just the result of smelling a pure chemical in a lab,” Lorkiewicz said. “So, we objectively can tell when someone is not working in an office at a desk, but they actually go outside and are surrounded by greenness.”

Keith said the biomarker for greenness exposure is a breakthrough for the Green Heart Project, the Trager MicroForest project in downtown Louisville and other studies.

“We have been working with the overall premise that trees affect health in a positive way. Our mission in the Green Heart Project is to understand in some ways how they do that,” she said. “We have turned to the idea of using the human as the biomonitor of greenness in the human. We hope to use this to see changes in people’s overall exposure to greenness as we plant trees and determine whether those changes correlate to changes in health.”

To assess people’s exposure to trees and plants, Keith combines the limonene biomarker test with satellite images showing tree density where people live and surveys of their time spent outdoors and compares the exposure information with health data such as blood pressure and heart rate.

In additional research, Keith and her team are using the biomarker to compare the health effects of limonene and other compounds emitted by plants on the body.

The University of Louisville School of Medicine is proud to announce the appointment of interim dean Jeffrey Bumpous, MD, to president of the American Board of Otolaryngology – Head and Neck Surgery (ABOHNS).

The president of the American Board of Otolaryngology-Head and Neck Surgery (ABOHNS) holds a vital position within the organization, tasked with overseeing various facets of board operations, growth, and mission fulfillment. In this role, Bumpous will play a key role in leading the certification processes, which encompasses primary certification in the specialty, subspecialty certifications, focused practice designations, and continuous certification. This includes working with executive leadership and committee chairs to develop examination materials, organize assessments, and review credentials and ethics issues.

Bumpous is working with the board on significant enhancements to the primary certification process by incorporating additional peer review and an oral exam based on physicians' own cases in practice. The goal is to execute this process in a fair, equitable, meaningful, and efficient manner, thereby upholding public confidence and trust in the board. The board has a newly published strategic plan which aligns with its mission, vision, and core purpose; Bumpous hopes to embrace these strategic initiatives and drive positive initiatives within ABOHNS to advance its commitment to professional excellence and public trust.

The impact Bumpous hopes to have on ABOHNS is deeply rooted in the organization's rich history and commitment to serving the public. Entering its 100^th year as a medical board, the organization remains dedicated to evolving with the medical landscape, embracing advancements such as technology, artificial intelligence, and changing practice models. By adopting a forward-thinking approach as outlined in its Strategic Plan, ABOHNS aims to uphold its core values while adapting to contemporary practices to ensure the delivery of high-quality healthcare services to the public.

“We aim to be innovative in how we adapt with the changing medical landscape and how that applies to the practice of Otolaryngology-Head and Neck Surgery,” said interim dean Jeffrey Bumpous, “It is an honor to get to be a part of leading that charge.”

The American Board of Otolaryngology-Head and Neck Surgery serves a critical role in the healthcare ecosystem by prioritizing the needs of the public above all else. Unlike many trade organizations that focus on promoting specialties or professionals, ABOHNS places a strong emphasis on serving the recipients of healthcare. The organization is committed to providing accessible, safe, caring, and effective healthcare services to individuals relying on its expertise. By maintaining a steadfast focus on patient welfare, ABOHNS demonstrates its unwavering dedication to upholding the highest standards of medical practice.

Read more on the ABOHNS and dean Bumpous’s appointment on the ABOHNS website.

The Kentucky Derby Festival Royal Court, a prestigious tradition in the state of Kentucky, not only emphasizes the glamour and elegance associated with the revered Kentucky Derby but also symbolizes a commitment to community engagement and personal growth. Two medical students from the University of Louisville School of Medicine were named Derby Princesses for the 2024 Kentucky Derby Festival. Ankita Nair, a third-year medical student, and Sarah Downs, a second-year medical student, were selected to represent the commonwealth.

The role of a Derby Princess embodies a unique blend of community engagement, tradition, and personal growth. Nair and Downs are both proud Kentucky natives and exemplify a deep-rooted connection to their community by embracing the rich traditions of the Kentucky Derby Festival.

Nair, a proud California-Kentuckian, embodies a strong connection to her roots, having divided her life between Louisville and San Diego. Her passion for community service and promoting preventative health initiatives shines through her involvement in the Kentucky Derby Festival. As a previous competitor in Miss Kentucky, she leverages her platform to educate and promote healthy lifestyle habits through her initiative "Let's Live Kentucky." Moreover, her involvement as a medical student demonstrates a holistic approach to her future career, combining academic pursuits with a deep commitment to community well-being.

Similarly, Downs believes being a Derby Princess allows her to serve her community and develop robust communication skills essential for her career as a physician. Her eagerness to connect with individuals from diverse backgrounds reflects in her understanding of others' stories and perspectives. Downs aspires to be a bridge between the local community and the global visitors who converge upon Kentucky during the Derby festivities.

Both Nair and Downs demonstrate a keen understanding of the significance of their roles as Derby Princesses. Their enthusiasm for the program is palpable as they share their eagerness to connect with people across various neighborhoods, support community initiatives, and contribute to the greater celebrations of Kentucky's traditions. Nair’s desire to engage with local businesses, volunteer in the West End, and bring attention to the diverse festivities symbolizes a deep commitment to community engagement. Similarly, Downs’s focus on impacting Kentucky’s youth and instilling in them the belief of pursuing one's dreams illustrates her dedication to inspiring and uplifting the next generation.

The experiences and aspirations of Nair and Downs exemplify the transformative impact of the Derby Princess role on their personal and professional development. Nair highlights how the role has equipped her with valuable time management, public speaking, and civic leadership skills, crucial for achieving a balance between professional endeavors and community engagement. Conversely, Downs emphasizes the role's contribution to refining her empathy and organizational skills, essential qualities for her future as a physician.

The attachment of Downs to the Kentucky Derby Festival, and her admiration for the Fillies and the Festival organizers, underlines the profound impact of these institutions on the social, cultural, and historical fabric of Kentucky. “We have some of the richest traditions here in our state and I am incredibly thankful for the opportunity to experience these traditions firsthand,” said Downs.

Nair’s admiration for the historical traditions of the Derby Festival highlights the significance of these organizations in uplifting the community and preserving Kentucky's traditions. “We started the Kentucky Derby 150 years ago and while many things have changed, the Derby continues to be a constant symbol of the rich history of Kentucky,” said Nair. “The Derby reminds me we have the grandson of Lewis and Clark to thank for the first running; that agriculture and horse farming have been and will always be something to be proud of; that steamboats like the Belle of Louisville tell the story of how Louisville came to be: first as a port city for Westward Expansion and now as a global UPS hub. The Kentucky Derby is a meaningful event that quintessentially shows our home to the rest of the world and is also something that we cherish here locally with all our festival events and traditions.”

As dedicated medical students and future healthcare professionals, they embody the essence of holistic engagement, combining academic pursuits with a commitment to community service and cultural celebration. Their dedication to embracing the Kentucky Derby Festival's traditions and uplifting the local community resonates as a testament to the enduring legacy of the Derby Princess program and its impact on shaping future leaders and advocates for social good.

The University of Louisville School of Medicine is proud of both Nair and Downs’ commitment to their academic pursuits and community engagement. Congratulations to Ankita Nair on being named the Derby Queen for the 150th running of the Kentucky Derby!

Heart disease is the number one cause of death worldwide, according to the World Health Organization, but scientists still do not understand all the factors that affect heart health.

University of Louisville environmental medicine researchers are working to better understand how natural, social and personal environments affect health, particularly the cardiovascular system. In recent months, the National Institutes of Health have awarded four grants totaling $11.6 million to researchers affiliated with UofL’s Christina Lee Brown Envirome Institute to study factors affecting heart health. Through these projects, they hope to better understand how environmental exposures and tobacco products can affect the cardiovascular system, as well as how remodeling takes place in the heart after a heart attack.

“The unique and synergistic research collaborative we have built at the Envirome Institute already has resulted in new discoveries about the biological and the environmental factors that contribute to heart disease,” said Aruni Bhatnagar, chief of the UofL Division of Environmental Medicine and director of the Envirome Institute. “Our studies funded by these new grants will lead to better understanding of the causes and progression of cardiovascular disease and new ways to protect and improve cardiovascular health.”

The new projects address the cardiovascular effects of newly introduced ingredients in electronic cigarette liquids, exposure to benzene, prenatal and infant exposure to combinations of substances and their impact on sleep in adolescence and the metabolic processes occurring after a heart attack that result in scarring in the heart.

One grant provides $3.3 million to investigate how exposure to benzene affects blood vessels. Sanjay Srivastava, professor of medicine who leads the project, said preliminary research shows that benzene worsens atherosclerosis, an underlying cause of cardiovascular disease and stroke. Atherosclerosis, a buildup of fatty deposits in arteries, reduces blood flow and flexibility of the arteries. Benzene is one of the top 20 pollutants from industrial sources in the United States, primarily from gasoline refineries. Outside industrial locations, exposure is higher near gas stations and from automobile exhaust and cigarette smoke. Benzene is known to cause cancer, but this is the first study to evaluate the effects of the chemical on heart disease, especially at levels typically experienced in the environment.

Cardiac fibrosis is essential for upholding the structure of the heart after heart attack, but also tends to produce excessive scar tissue and stiffening of the heart. Bradford Hill is examining the processes behind stiffening and scarring in the heart following myocardial infarction. A $2.3 million grant is funding the professor of medicine’s work to investigate the metabolic processes underlying this process. Hill hopes the work will lead to a therapy that supports the repair process but also reduces excessive scarring, allowing heart attack patients to fare better down the road.

Clara Sears, assistant professor of environmental medicine, received a $2.1 million grant for a project to discover how exposure to mixtures of common chemicals and pollutants before birth and in infancy affects sleep health in adolescence. Ultimately, she hopes to understand whether exposures to phthalates (common components of plastics), metals and per-/polyfluoroalkyl substances (PFAS – known as “forever chemicals”) may be linked to cardiovascular issues later in life.

The largest of the grants, $3.9 million, will fund research into potential toxicity of new synthetic cooling compounds that are being used in electronic cigarette liquids. Daniel J. Conklin leads the project to learn whether these compounds are harmful to the cardiovascular and pulmonary systems when heated and inhaled. The compounds mimic the cooling effect of menthol, which can be irritating in high doses, but they have not been tested for safety or toxicity as inhaled substances. For this new project, Conklin, a professor of medicine who has studied the cardiovascular effects of e-cigarette and cigarette components for more than two decades, is testing the effects of the new constituents as well as documenting the impact of dual use – smoking conventional cigarettes along with vaping. The Food and Drug Administration’s Center for Tobacco Products will use the results of these studies to determine potential recommendations to regulate the products’ use.

“We are going to address the issue of dual use, where there are both cigarettes and e-cigarettes in use, because this is a very common phenomenon and the signals are coming that it’s actually worse than either one alone,” Conklin said.

University of Louisville researchers and their collaborators have won a Phase 2 prize in a $9.8 million National Institutes of Health innovation competition aimed at helping spinal cord injury patients regain function.

The four Phase 2 winners in the NIH’s Neuromod Prize competition each will receive $1 million, technical assistance and other resources to accelerate the development for neuromodulation therapies — those aimed at stimulating the nervous system to improve function and treat a range of conditions. At UofL, researchers are using these therapies to help patients with paralysis restore functions they may otherwise never have again.

“This technology holds enormous potential for people living with paralysis resulting from spinal cord injury,” said Susan Harkema, a UofL professor, researcher and lead on the Neuromod Prize project. “Our research so far, and the progress we will make supported by this new funding, could dramatically improve all aspects of their daily lives, from movement to cardiovascular function.”

The project team includes UofL Kentucky Spinal Cord Injury Research Center researchers Harkema and Charles Hubscher, working in collaboration with Johns Hopkins University Applied Physics Laboratory (APL), Medtronic and long-time clinical translational research partner, the Kessler Foundation. Together, they will develop a novel communication and analysis system, called StimXS, that integrates sensor information to both stabilize blood pressure and improve respiratory and bladder function.

This builds on past work and technology developed by UofL researchers, who have used neuromodulation to target and improve a range of health effects resulting from spinal cord injury, including cardiac, respiratory and bladder function and even the ability to walk — something previously thought to be impossible. To target these functions, the researchers use an implantable stimulation device that can send electrical signals to select areas of the spinal cord.

“With this new Phase 2 Neuromod funding, we can take a major step toward advancing this technology for broad use in patients,” said Hubscher, professor and co-director of the KSCIRC. “We’ve seen great results in the lab, but the true impact of this technology will be when it’s in a clinical setting and helping the people who need it most.”

This work has also been supported by several public and private sponsors, such as the Christopher and Dana Reeve Foundation, the Craig H. Neilsen Foundation, the Helmsley Charitable Trust and multiple grants from the NIH. As part of the Neuromod Prize, Phase 2 winners will be exclusively invited to participate in Phase 3, which will have a total potential prize pool of $5 million.  

“This is truly game-changing research with the power to improve lives,” said Jon Klein, UofL’s interim executive vice president for research and innovation. “I applaud the research team for their success in driving this important work forward and am excited to see them translate this for broad use in patients.”

The Neuromod Prize is part of the NIH Common Fund’s Stimulating Peripheral Activity to Relieve Conditions (SPARC) program, which is making critical progress to help accelerate the development of neuromodulation therapies, close fundamental knowledge gaps, and offer tools that enable open science and innovation through the SPARC Portal.

University of Louisville School of Medicine fourth-year medical students had a lot to celebrate March 15th for Match Day. The highlight of Match Day is when prospective medical residents open their envelopes from the National Residency Match Program to discover where they have been matched for their future training as residents.

The Match is conducted annually by the NRMP and uses a computerized algorithm that aligns the preferences of applicants with the preferences of residency programs. These results are then used to fill thousands of training positions all throughout the United States.

“I am deeply pleased with this talented class of future residents and wish them all the best of luck in their pursuits wherever they matched.” said Jeffrey Bumpous, MD, interim dean for the School of Medicine.

This year’s Match Day was held at Angel’s Envy Bourbon Club at L&N Federal Credit Union Stadium. The event was attended by approximately 600 people excited to see where our future residents would match.

“Match Day marks a pivotal milestone,” said Umair Bhutto, 2024 class president. “It is a real testament to our hard work, and we now stand on the threshold of our futures. I am grateful I get to witness my peers as they discover where they will be during the next step in their medical journey.”

Congratulations to all our medical students who matched on match day! The University of Louisville School of Medicine is so proud and wishes you all the best of luck in your future endeavors both in medical residency and in your future careers.

Visit the photo gallery to view images from the event.

Age-Friendly Louisville (AFL) continues its mission to create an inclusive city for individuals of all ages and abilities. Led in partnership since 2016 by Louisville Metro Government, AARP Kentucky, KIPDA, and the UofL Trager Institute, AFL's efforts span various domains, from infrastructure and health services to social connections. AFL is in the process of drafting its 2024 – 2027 Strategic Plan within the new domain workgroups, focusing on Housing, Social Inclusion, and Outdoor Enhancement.

2024 Kickoff Event

AFL recently hosted its Kickoff Event on January 25th, reintroducing the new workgroup domains and inviting community participation. Workgroup meetings are held monthly at the Edison Center, providing residents with opportunities to shape AFL's future through engaging discussions and advocacy efforts. Join Us!

New Domains

Housing: Creating age-friendly, multigenerational communities and enhancing accessibility to home modifications.

Social Inclusion: Promoting accessible and affordable social activities, celebrating community diversity, and fostering collaboration.

Outdoor Enhancement: Improving public spaces, promoting mobility, and ensuring safer streets.

Clara Sears is fascinated by sleep. Quality sleep is essential to support growth and development and many adolescents in the U.S. are not getting enough.

“Everyone sleeps and it’s fascinating to me. We know so little about sleep scientifically that it really piqued my interest, and my project is right at the intersection of cardiovascular health and neurodevelopment, so it is kind of the perfect niche for my interest,” said Sears, assistant professor of environmental medicine, a researcher in the University of Louisville’s Christina Lee Brown Envirome Institute and a UofL alumna.

Sears is leading a project to discover how exposure to mixtures of common chemicals and pollutants during gestation and infancy affects sleep health in adolescence. Ultimately, she believes the exposures may be linked to cardiovascular issues later in life. Her work is part of research at the Envirome Institute to understand the relationships between the environment and human health.

“Sleep is increasingly recognized to be central to cardiovascular health. We know that a variety of lifestyle choices and environmental factors affect sleep, but we know little about the effects of chemical exposure and pollutants,” said Aruni Bhatnagar, professor of medicine and director the Envirome Institute. “Clara's work could provide new knowledge about factors that affect sleep, particularly in adolescents, so that we can improve their quality of sleep and future cardiovascular health.”

Sears’ team is examining exposure to combinations of phthalates (common components of plastics), metals and per-/polyfluoroalkyl substances (PFAS – known as “forever chemicals”). People are frequently exposed to these toxicants through their diet, as well as use of consumer goods and household products. Sears said they chose to study mixtures rather than individual chemicals because most people in the U.S. are exposed to them in combination.

“We know pregnant women and children are exposed to these chemicals in mixtures and sometimes they can affect similar biological pathways, or they can interact in ways that may magnify an effect on a health outcome,” Sears said. “So, if we study them in isolation, it is hard to get the real-world relevance of how they interact with each other to affect health.”

The work is funded by a five-year, $2.1 million grant from the National Institutes of Health to determine whether there are connections between these early exposures and poor sleep quality and increases in allostatic load in adolescents. Allostatic load is the cumulative burden of “wear and tear” on the body resulting from stressors that eventually can disrupt an individual’s immune, cardiovascular and metabolic functions. A person’s allostatic load can be assessed through biomarkers and other measures such as inflammation and body composition.

Sears is working with experts in pediatric environmental health, sleep and cardiometabolic health to analyze data from two long-term studies that track prenatal and early life exposures and other health information. The Health Outcomes and Measures of the Environment Study and the Maternal-Infant Research on Environmental Chemicals Study have documented exposures and other health measures in more than 550 children from before birth through pre-teen and teen years, along with sleep health in adolescence.

Sears hopes the study will lead to understanding the link between early life environmental factors and cardiovascular health later in life, informing efforts to improve the environment for infants and children so that they can be healthier into adulthood.

“Sleep impacts every aspect of your health and your day-to-day functioning, so if we can find ways to improve sleep it can have huge impacts on health overall.”

See previous sleep research from the Envirome Institute: Reduced sleep linked to environmental factors | UofL News

The University of Louisville School of Medicine is committed to pursuing groundbreaking research that positively impacts the community, the commonwealth, and beyond. Eating disorders affect an estimated 9% of Americans — nearly 30 million people — and can impact a person’s eating behaviors and perceptions about food and their bodies. Cheri Levinson, Ph. D., HSP, is an associate professor at the University of Louisville and is the founder of the Louisville Center for Eating Disorders. Levinson specializes in the study and intervention of eating and anxiety disorders and leads innovative research funded by the National Institutes of Health (NIH). For National Eating Disorder Awareness Week, we sat down with Dr. Levinson to better understand her research in eating disorders.

ULSOM: What has been your motivation to pursue eating disorder research? 

Levinson: Growing up I had many friends and family members who had eating disorders and there was nowhere for them to go to get help. I wanted to understand the illnesses more and so when I started doing psychology research, I was drawn into research on eating disorders that would help me understand how to better help those impacted by these deadly diseases.

ULSOM: How did receiving the NIH New Innovator Award impact you? 

Levinson: I am just so excited! This award is amazing because it allows me and my team to do what I think is extremely important work developing a personalized treatment for eating disorders and doing it in the way that I think will lead to the most success. I've also always been told I am an ‘out of the box’ thinker, which is not always rewarded with traditional funding mechanisms, so it is extremely validating to get this award and know that so many people are rooting for these ideas to become a success in a way that can positively impact society.

ULSOM: Who do you hope to see impacted by your research in eating disorders? 

Levinson: Everyone with an eating disorder and everyone who has ever loved or cared for someone with an eating disorder. I also think that this work will end up being extended to the whole field of psychology and psychiatry, meaning it has the potential to impact treatment development for all mental illnesses. I am very hopeful that we are going to be able to build a data-based personalized treatment that works for everyone and is easy to scale and implement in communities globally.

ULSOM: What impact does the personalization of eating disorder treatment have on those being treated?

Levinson: We are finding that personalization really improves treatment adherence (meaning people are more likely to stick with treatment) and that it significantly reduces not only eating disorder symptoms, but also symptoms of depression, worry, and anxiety, and improves quality of life. I think the ability to personalize treatment to one person is so important because every eating disorder looks different. Using treatments not designed for the specific person leaves so much out of treatment that is needed for successful recovery.

ULSOM: In what ways do you see underserved populations go unnoticed in eating disorder research and treatment?

Levinson: Eating disorders impact people of all genders, ages, ethnicities, sexual identities, socioeconomic status, and body size. Unfortunately, most of our research and treatment access to date has been for white females. We need more research that includes everyone with all their unique identities and experiences.

ULSOM: How do you see eating disorder research and treatment changing for the next generation?

Levinson: I think we are going to see a huge focus on more inclusive research, the use of technology and digital treatments to improve treatments, and a focus on dismantling systems like food insecurity and weight stigma to improve outcomes.

ULSOM: How has the University of Louisville School of Medicine played a role in advancing your research?

Levinson: My primary appointment is in psychological and brain sciences in arts and sciences, and I just joined pediatrics this summer. Overall, UofL has always been extremely supportive of my work and providing the resources and support I need to grow the research impact and team of people who are dedicated to doing this type of work.

The University of Louisville School of Medicine recognizes Dr. Levinson and her advances in the field of eating disorder treatment. If you or someone you know is struggling, we encourage you to reach out for help and seek treatment.

University of Louisville researchers have developed a new AI-powered tool that could help doctors diagnose autism at a younger age.

Autism is a spectrum of developmental disabilities effecting social skills, language processing, cognition and other functions. The UofL tool has been shown to be 98.5% accurate in kids as young as two, which could give doctors more time to intervene with potentially life-changing therapy. Their results were published in the journal Biomedicines.

“Therapy could be the difference between an individual needing full-time care and being independent, holding a job and living a fulfilled life,” said Ayman El-Baz, a co-inventor and professor and chair in the J.B. Speed School of Engineering. He developed the technology with Gregory Barnes and Manuel Casanova of the UofL School of Medicine.

Research shows therapy can have the most impact if done in early childhood, when the brain is more elastic. However, currently, less than half of kids are tested before age three and even fewer are diagnosed by age eight. The problem, the researchers say, is one of supply and demand — there are too many patients and too few specialists to conduct the interviews and examinations needed for diagnosis.

“As a result, there’s an urgent need for a new, objective technology that can help us diagnose kids early,” said Barnes, a professor of neurology and executive director of the UofL Autism Center. “We think our tool can help fill that need, while providing more objectivity over the current interview method.” 

With the UofL technology, AI can make the initial diagnosis, which researchers think could reduce specialist workload by as much as 30%. The specialist would meet later with the patient to confirm the diagnosis and talk about next steps. 

The UofL technology works by using AI to analyze magnetic resonance imaging (MRI) scans for differences and abnormal connections that may indicate autism. Tested against scans of 226 children between the ages of 24 and 48 months, the technology was able to identify the 120-some children with autism with near perfect accuracy. 

By looking at the physical structures of the brain rather than using interviews, researchers believe they can make diagnoses more objective and target the specific parts of the brain that may benefit most from therapy. 

“The idea is that by drawing from both medicine and engineering, we can come up with a better solution that improves lives,” said Mohamed Khudri, a bioengineering undergraduate student and author on the paper. 

The diagnostic technology and intellectual property received support through UofL’s Office of Research and Innovation. That includes the office’s suite of innovation programs, aimed at developing research-backed inventions for market, including the prestigious national Innovation Corps (I-Corps) program through the National Science Foundation. UofL is one of only a handful of universities nationwide to have each of these programs — and it’s the only one to have them all.

The University of Louisville School of Medicine is committed to uplifting the women who play a pivotal role in making the research and clinical care at our institution possible every day. For International Women and Girls in Science Day, we are highlighting one of our many dedicated women in science, Dr. Dawn Caster.

Caster is a clinician scientist who specializes in Nephrology (kidney diseases) specifically glomerular diseases which are autoimmune kidney diseases. She serves as an associate professor and the co-director of research for the division of Nephrology and Hypertension. Caster is a recognized researcher in the field of glomerular diseases, with a translational lab that is focused on identifying novel biomarkers in lupus nephritis and evaluating mechanisms of inflammation in lupus nephritis.

Pursuing medicine wasn’t always Caster’s plan for herself. She didn’t start college on the “pre-med” track. Instead, she obtained dual undergraduate degrees in Nutrition (BS) and Sociology (BA). She became more interested in medicine as she progressed through college because she enjoyed both her science and humanities courses. “I think that Medicine is a great intersection of science and humanities,” said Caster.

Many components inspired Caster’s motivation to pursue clinical medicine. Her mother was a teacher who encouraged her from a young age to pursue an education and a career. Her decision to specialize in Nephrology was motivated by both her mother’s diagnosis of kidney disease and the many strong role models and mentors in the division. “I was fortunate to have exposure to many amazing female faculty members,” said Caster. Caster highlighted Dr. Eleanor Lederer (former ULSOM interim chair of medicine and former president of the American Society of Nephrology) and Dr. Rosemary Ouseph (now ULSOM division chief) as faculty that directly inspired her to pursue academic medicine. 

The passion for research came to Caster later from a patient interaction during her training. During her Nephrology fellowship, she encountered a young patient with lupus nephritis that ended up in kidney failure at 18 years old. “I was frustrated with the outcome and wanted to understand more about the disease,” said Caster.  Soon after, she became involved in a research project on lupus nephritis and the project evolved into her scientific career. 

Caster hopes to make a difference for young girls pursuing a career in science or medicine. She highlighted the importance for young girls to have role models in their chosen career fields, as she did. “It is critical for girls and young women to see successful women in science so that they can know this is possible for them,” said Caster.

As the number of women and girls in science and medical fields grows, Caster hopes to see these young women and girls taking up space in these fields. “When I was younger, I was often worried about making the “wrong” choice or failing at something,” said Caster “I also hope that they will be inspired to speak up more, ask more questions, and not be afraid of failure.”

The 2024 University of Louisville Health Sciences Pre-Health Symposium will take place on Saturday, February 10^th in the Instructional Building of the School of Medicine. The goal of the Pre-Health Symposium is to provide all high school, community college, and university students, who have an interest in the health sciences, with the information and tools necessary to succeed in the professional and graduate school admissions process. The University of Louisville Schools of Dentistry, Medicine, Nursing and Public Health & Information Sciences will have representatives on hand to discuss with students the skills needed to navigate the road to higher education.

This year's Pre-Health Symposium will feature Dr. Trinidad Jackson. In May 2022, Jackson earned his Ph.D. in Public Health Sciences. He is currently the inaugural Assistant Dean for Culture and Liberation and an assistant professor at SPHIS; he also holds a joint appointment as a Senior Advisor within the government sector and is the CEO of a company that prioritizes culture, liberation, art and science. His keynote will address “Leveling the Scales” highlighting social justice and equity in healthcare.

To learn more about the Pre-Health Symposium, the University of Louisville School of Medicine interviewed Sharon Gordon, MS, the Pre-Health Symposium event coordinator.

ULSOM: What is the Pre-Health Symposium? 

Gordon: A forum to share information about the professional schools at HSC and the many STEM careers available to their graduates.

ULSOM: Why was the Pre-Health Symposium created?

Gordon: The symposium was the brainchild of two former students, one medical and one dental, to provide information to those who would one day follow in their footsteps.Their hope was to educate, provide resources, and the opportunity for guidance and mentorship to college students, in return leading to an increase in the number of applicants from populations typically underrepresented in professional school. The symposium has now grown to provide these same opportunities to all students in the area.

ULSOM: What is the ultimate goal of the Pre- Health Symposium? 

Gordon: To connect local and regional youth interested in STEM careers with UofL professional students and administrators to share information, resources and advice.

ULSOM: Who do you hope to reach with the Pre-Health Symposium? 

Gordon: The symposium is open to everyone, especially student populations that have been historically underrepresented in dentistry, medicine, nursing and public health. 

ULSOM: Who is the ideal participant for the Pre-Health Symposium?

Gordon: A local high school or undergraduate student with an interest in dentistry, medicine, nursing or public health.

ULSOM: What topics will be covered at the Pre-Health Symposium? 

Gordon: Social justice, health equity, STEM careers, resumes, personal statements, mental health, shadowing, volunteering, admission requirements.

ULSOM: What effect have you observed the Pre-Health Symposium has had on those interested in pursuing health and medical fields? 

Participants who have attended the Pre-Health Symposium leave the forum with more knowledge of what is required to obtain a successful career in the STEM field; including the classes to enroll in as well as the extracurricular activities to involve themselves in before they apply.  Our hope is that by sharing these resources with a younger population, that they are better prepared and more confident as they navigate the road to professional school.